The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $33.56

Today's change-0.21 -0.62%
Updated June 29 4:02 PM EDT. Delayed by at least 15 minutes.
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $33.56

Today's change-0.21 -0.62%
Updated June 29 4:02 PM EDT. Delayed by at least 15 minutes.

Reversal following new 20-day high

Omega Healthcare Investors Inc closed lower Wednesday, dropping (U.S.)$0.21 or 0.62% to (U.S.)$33.56 after setting a new 20-day high. Over the last five days, shares have gained 4.84%, but are down 4.06% for the last year to date. Shares have underperformed the S&P 500 by 3.98% during the last year.

Key company metrics

  • Open(U.S.) $33.96
  • Previous close(U.S.) $33.77
  • High(U.S.) $34.16
  • Low(U.S.) $33.19
  • Bid / Ask-- / --
  • YTD % change-4.06%
  • Volume1,881,815
  • Average volume (10-day)1,447,883
  • Average volume (1-month)1,402,143
  • Average volume (3-month)1,236,173
  • 52-week range(U.S.) $26.96 to (U.S.) $37.24
  • Beta0.75
  • Trailing P/E27.81×
  • P/E 1 year forward18.87×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.32
  • Dividend yield6.91%
  • Trailing EPS(U.S.) $1.21
Updated June 29 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+30.19%

Based on its net profit margin of 30.19%, Omega Healthcare Investors Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.40%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue213211202198
Total other revenue--------
Total revenue213211202198
Gross profit--------
Total cost of revenue--------
Total operating expense1168676123
Selling / general / administrative16201010
Research & development--------
Depreciation / amortization62616059
Interest expense (income), net operating--------
Unusual expense (income)385554
Other operating expenses, total--------
Operating income9712512674
Interest income (expense), net non-operating-39-41-40-40
Gain (loss) on sale of assets20-29
Other--------
Income before tax58648444
Income after tax58648343
Income tax, total0001
Net income56617941
Total adjustments to net income--------
Net income before extra. items56617941
Minority interest-3-3-4-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items56617941
Inc. avail. to common incl. extra. items56617941
Diluted net income56617941
Dilution adjustment----00
Diluted weighted average shares198198195194
Diluted EPS excluding extraordinary itemsvalue per share0.280.310.410.21
Dividends per sharevalue per share0.570.560.550.18
Diluted normalized EPSvalue per share0.460.330.450.44